市場調査レポート
商品コード
1468358
泌尿器科ロボット手術市場レポート:コンポーネント、用途、地域別、2024~2032年Urology Robotic Surgery Market Report by Component (Robotic Surgery Systems, Instruments and Accessories, Services), Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
泌尿器科ロボット手術市場レポート:コンポーネント、用途、地域別、2024~2032年 |
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
|
世界の泌尿器科ロボット手術市場規模は2023年に18億米ドルに達しました。今後、IMARC Groupは、2024~2032年にかけて9.2%の成長率(CAGR)を示し、2032年までに41億米ドルに達すると予測しています。特に高齢者人口における骨変性疾患や腎臓・尿路疾患の有病率の増加、膝関節置換術や股関節置換術に対する低侵襲補助手術の需要の高まりが、市場を牽引する主要因の一つとなっています。
泌尿器科ロボット手術は、小型化されたコンピューター制御のマニピュレーターや手術器具にビデオカメラや人工センシングソリューションを搭載した低侵襲治療です。これらの器具は、医療専門家の監視の下、様々なロボットコンソールによって、大きな切開の代わりに小さな穿孔に設置され、遠く離れた重要なスペースに到達し、手術部位の高度に拡大された鮮明な3次元(3D)画像を見ることができます。標準的な機器として、ロボットマシン、ナビゲーションシステム、シミュレーター、プランナー、その他の重要な付属品が含まれます。泌尿器科のロボット手術は、正確な動作と倍率の向上、生産性の最大化、治療手順中の仲間との連携の確保、回復時間、出血、術後合併症の最小化を実現します。これ以外にも、瘢痕、痛み、不快感、感染リスクを軽減し、入院期間を短縮し、より良い臨床結果をもたらします。その結果、泌尿器科ロボット手術は、前立腺摘除術、膀胱摘除術、腎摘除術、腎盂形成術などの外科手術に病院やクリニックで広く利用されています。
腎臓または尿路疾患の有病率の増加は、市場成長を促進する重要な要因の1つです。このような病気にかかりやすい高齢者人口の増加も市場成長に寄与しています。これに伴い、膝関節置換術や股関節置換術に対する低侵襲補助手術の需要が高まっているが、これは従来の外科手術に比べて複数の利点があるためであり、これも成長を促す要因となっています。さらに、人為的ミスの可能性を大幅に減らす自動化された手術器具に対するニーズの高まりが、市場の成長を促しています。さらに、医療従事者が複雑な解剖学的構造にアクセスして治療し、診断手続きの精度を高めることを可能にするロボット支援軟性内視鏡のシステムとの統合は、市場成長に有利です。さらに、ソフトウェアによる遠隔動作中心(RCM)や複雑な動作制御機能を備えたモジュラー型ロボット手術システムの登場が、市場の成長を後押ししています。これとは別に、有効性を高めた泌尿器科手術ロボットを製造するための継続的な研究開発(R&D)活動や、手術介入のための製品の多様化が市場の明るい展望を生み出しています。その他にも、医療予算の増加や医療インフラの改善などが、市場の成長を後押ししています。
The global urology robotic surgery market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032. The increasing prevalence of bone degenerative and kidney or urinary tract diseases, especially amongst the geriatric population, along with the rising demand for minimally invasive assisted surgeries for knee and hip replacements, represent some of the key factors driving the market.
Urology robotic surgery is a minimally invasive treatment that includes miniaturized computer-controlled manipulators and surgical instruments with a video camera and artificial sensing solutions. These devices are placed in small punctures instead of large incisions by various robotic consoles under the supervision of healthcare professionals to reach distant and critical spaces and view highly magnified and clear three-dimensional (3D) pictures of the area to be operated. It encompasses robotic machines, navigation systems, simulators, planners, and other crucial accessories as standard equipment types. Urology robotic surgery offers accurate motions and increased magnification, maximizes productivity, ensures peer collaborations during treatment procedures, and minimizes recovery time, blood loss, and post-surgical complications. Apart from this, it reduces scarring, pain, discomfort, and the risk of infection ensures shorter hospitalization and provides better clinical outcomes. As a result, urology robotic surgeries are extensively utilized in hospitals and clinics for prostatectomy, cystectomy, nephrectomy, and pyeloplasty surgical procedures.
The increasing prevalence of kidney or urinary tract diseases represents one of the key factors driving the market growth. The increasing geriatric population, which is susceptible to such ailments, is also contributing to the market growth. In line with this, the rising demand for minimally invasive assisted surgeries for knee and hip replacements, due to their multiple benefits over traditional surgical procedures, is acting as another growth-inducing factor. Additionally, the rising need for automated surgical tools that significantly reduce the chances of human errors is driving the market toward growth. Moreover, the integration of robot-assisted flexible endoscopes with the system that enables healthcare practitioners to access and treat complex anatomies and enhance precision in diagnostic proceedings is favoring the market growth. Furthermore, the advent of the software-enforced remote center of motion (RCM) and modular robotic surgical systems with complex motion control capability is impelling the market growth. Apart from this, the ongoing research and development (R&D) activities to manufacture urology surgical robots with enhanced efficacy and the fueling number of product diversification for surgical interventions are creating a positive outlook for the market. Other factors, such as increasing healthcare budgets and improving healthcare infrastructure, are driving the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global urology robotic surgery market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on component and application.
Robotic Surgery Systems
Instruments and Accessories
Services
The report has also provided a detailed breakup and analysis of urology robotic surgery market based on the component. This includes robotic surgery systems, instruments and accessories and services. According to the report, instruments and accessories represented the largest segment.
Robotic Prostatectomy
Robotic Cystectomy
Robotic Pyeloplasty
Robotic Nephrectomy
Others
A detailed breakup and analysis of the urology robotic surgery market based on the application has also been provided in the report. This includes robotic prostatectomy, robotic cystectomy, robotic pyeloplasty, robotic nephrectomy and others. According to the report, robotic prostatectomy accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for urology robotic surgery. Some of the factors driving the North America urology robotic surgery market included the increasing prevalence of kidney and urinary tract diseases and the rising geriatric population.
The report has also provided a comprehensive analysis of the competitive landscape in the global urology robotic surgery market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Intuitive Surgical Inc., Johnson & Johnson, Medtronic plc, Stryker Corporation, Surgical Science Sweden AB, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.